Atom | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Funder: National Institutes of Health

Funding Amounts: Up to $650,000 direct costs per year for each phase (UG3 and UH3); maximum project period is 5 years (UG3: 1–3 years, UH3: 2–4 years).

Summary: Supports collaborative, innovative projects to accelerate translational research by developing, demonstrating, and disseminating new approaches, technologies, or models across the CTSA Program Consortium and beyond.

Key Information: Limited competition; requires collaboration among at least three eligible organizations; strict eligibility and submission requirements.

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Sign in to see full grant listing